Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Clinical Research Organizations-CROs -- Ignore unavailable to you. Want to Upgrade?

To: Muse who wrote (14)	12/3/1999 1:33:00 PM
From: RWReeves	Respond to of 46

The RWR research group of monkeys with typewriters has compiled the following comparison chart: quicken.excite.com Now don't panic when you see it. Adjust the time scale back and forth, remove the issues one at a time and put them back. You see the pattern pretty quick. Now I don't know about the rest of y'all, but to me it says "Buy me". (Actually it said that in Sept, now its starting to say "Thanks"- but theres room...) Anyway, what strikes me on this is a couple of things: QTRN, ever with significantly larger capitalization, was as volatile as the smallest of the group. CVGR, the 'bitty CRO, has shown pretty good strength relative to the group and is "leading the recovery". KNDL, which is my personal favorite, (worth checking out their website) has the greatest "beta" (i.e. took the biggest fall), and the simple argument can be made that given decent earnings, may have a stronger recovery of price. I think that we saw some of this in the last few weeks and I will watch this one closely. Not investment advice by any means, but given the urge to invest in a CRO, QTRN has the best visibility, liquidity, capitalization, etc. Braver souls (other terms HAVE been used) might look to the lower tiers in a speculative market. RWR